Again, injections of GBM cells with either control MSC or TGFB1-deficient MSC generated tumors at similar rates, with no significant changes in final tumor size and weight (Figure 2C–2D and Supplementary Table 1). This evidence concerns the gene TGFB1 and neoplasm.